Invivyd CMO reports 375,000 stock options

Invivyd, Inc. reports that CMO and Chief Epidemiologist Mina Michael beneficially holds a stock option to purchase 375,000 shares of common stock at an exercise price of $1.33 per share, expiring on March 31, 2036.

Rhea-AI Filing Summary

Invivyd, Inc. reports that CMO and Chief Epidemiologist Mina Michael beneficially holds a stock option to purchase 375,000 shares of common stock at an exercise price of $1.33 per share, expiring on March 31, 2036. The option vests over four years, with 25% vesting on March 5, 2027 and the remaining 75% vesting in substantially equal monthly installments over the following three years, subject to continuous service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mina Michael

Role CMO and Chief Epidemiologist

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy) F1	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 375,000 contracts (Direct)

Footnotes (1)

1. F1. This option vests over a four-year period, with 25% of the shares subject to the option vesting on March 5, 2027, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

Key Figures

Stock option underlying shares: 375,000 shares Exercise price: $1.3300 per share Option expiration date: 2036-03-31 +2 more

5 metrics

Stock option underlying shares 375,000 shares Underlying Invivyd common shares for stock option held by Mina Michael

Exercise price $1.3300 per share Exercise price of Mina Michael’s stock option

Option expiration date 2036-03-31 Expiration date of the reported stock option

Initial vesting date March 5, 2027 25% of the option shares vest on this date

Vesting period 4 years Option vests over four years, with remaining 75% in monthly installments

Key Terms

Stock Option (Right to Buy), underlying security, vesting, continuous service

4 terms

Stock Option (Right to Buy) financial

"Security title reported as "Stock Option (Right to Buy)" for Mina Michael."

underlying security financial

"The underlying security title is reported as common stock, the underlying security."

vesting financial

"This option vests over a four-year period, with 25% of the shares vesting on March 5, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continuous service financial

"Vesting is subject to the Reporting Person's continuous service as of each vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity position did Invivyd (IVVD) disclose for CMO Mina Michael?

Invivyd disclosed that CMO and Chief Epidemiologist Mina Michael holds a stock option over 375,000 common shares. The option has a $1.33 exercise price, a March 31, 2036 expiration, and vests over four years, subject to continued service.

How many Invivyd (IVVD) shares are covered by Mina Michael’s stock option?

Mina Michael’s reported stock option covers 375,000 shares of Invivyd common stock. These shares are underlying a single “Stock Option (Right to Buy)” position and become exercisable over a four-year vesting schedule tied to continued service with the company.

What is the vesting schedule for Mina Michael’s Invivyd (IVVD) stock option?

The option vests over four years, with 25% of the shares vesting on March 5, 2027. The remaining 75% vest in substantially equal monthly installments over the next three years at a rate of 1/48th per month, subject to continuous service.

What are the exercise price and expiration date of Mina Michael’s Invivyd (IVVD) option?

The stock option has an exercise price of $1.33 per share and expires on March 31, 2036. This gives a long-dated right to purchase Invivyd common shares once the option is vested and subject to any applicable exercise conditions.

Is Mina Michael’s Invivyd (IVVD) stock option held directly or indirectly?

The option is reported as held directly by Mina Michael. The ownership code is “D”, indicating direct beneficial ownership of the stock option position covering 375,000 underlying Invivyd common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:15 PM Accepted by SEC EDGAR 08/04/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mina Michael

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2026

3. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CMO and Chief Epidemiologist

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	03/31/2036	Common Stock	375,000	$1.33	D

Explanation of Responses:

1. This option vests over a four-year period, with 25% of the shares subject to the option vesting on March 5, 2027, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Jill Andersen attorney-in-fact for Michael Mina	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)